Back to Journals » Infection and Drug Resistance » Volume 5

Polypodium leucotomos Extract use to prevent and reduce the risk of infectious diseases in high performance athletes

Authors Marí Solivellas B, Cabanes Martín T

Received 9 January 2012

Accepted for publication 10 July 2012

Published 16 October 2012 Volume 2012:5 Pages 149—153


Review by Single-blind

Peer reviewer comments 4

Bartolomé Marí Solivellas, Teo Cabanes Martín

Sports Medicine Service, Mallorca Regional Government, Mallorca, Spain

Objective: Many components of the immune system undergo adverse changes during intense physical activity in athletes, leading to a heightened risk of respiratory tract infections. This study evaluated the reduction in infectious processes in athletes due to intensive training with anapsos.
Methods: The study compared athletes who took 480 mg Polypodium leucotomos Extract (Armaya fuerte; Centrum laboratories, Alicante, Spain) twice daily for 3 months (n = 50) with a control group (n = 50) in the evaluation of the onset of infectious processes and relapses during an 8-month period (June 2010 to January 2011).
Results: The onset of infectious processes in the Polypodium leucotomos Extract group was lower when compared to the control group (14% versus 56%). Relapse in the Polypodium leucotomos Extract group was seen in just one athlete (14.2%) compared to ten athletes (37.5%) in the control group.
Conclusion: Polypodium leucotomos Extract has been shown to be useful in the prevention of infectious processes, as well as reducing recurring episodes in athletes.

Keywords: immunological stress, recurrent infections, Polypodium leucotomos extract

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]